NO20073367L - Makrolider - Google Patents

Makrolider

Info

Publication number
NO20073367L
NO20073367L NO20073367A NO20073367A NO20073367L NO 20073367 L NO20073367 L NO 20073367L NO 20073367 A NO20073367 A NO 20073367A NO 20073367 A NO20073367 A NO 20073367A NO 20073367 L NO20073367 L NO 20073367L
Authority
NO
Norway
Prior art keywords
compounds
methods
macrolides
intermediates
antibacterial
Prior art date
Application number
NO20073367A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Victor Magee
Mark Edward Flanagan
Louis Stanley Chupak
Takushi Kaneko
Mark Carl Noe
Usa Reilly
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35809765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073367(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20073367L publication Critical patent/NO20073367L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Tires In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
NO20073367A 2004-12-21 2007-06-29 Makrolider NO20073367L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63809704P 2004-12-21 2004-12-21
US71753005P 2005-09-14 2005-09-14
PCT/IB2005/003829 WO2006067589A1 (en) 2004-12-21 2005-12-12 Macrolides

Publications (1)

Publication Number Publication Date
NO20073367L true NO20073367L (no) 2007-09-05

Family

ID=35809765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073367A NO20073367L (no) 2004-12-21 2007-06-29 Makrolider

Country Status (35)

Country Link
US (1) US7462600B2 (de)
EP (2) EP2233493A1 (de)
JP (1) JP4111994B1 (de)
KR (1) KR100897678B1 (de)
CN (1) CN101120011A (de)
AP (1) AP2007004026A0 (de)
AR (1) AR052824A1 (de)
AT (1) ATE459633T1 (de)
AU (1) AU2005317735B2 (de)
BR (1) BRPI0519135A2 (de)
CA (1) CA2591746A1 (de)
CR (1) CR9202A (de)
DE (1) DE602005019786D1 (de)
DK (1) DK1836211T3 (de)
EA (1) EA011281B1 (de)
ES (1) ES2339871T3 (de)
GE (1) GEP20094834B (de)
GT (1) GT200500378A (de)
HN (1) HN2005036113A (de)
HR (1) HRP20100253T1 (de)
IL (1) IL183661A0 (de)
MA (1) MA29108B1 (de)
MX (1) MX2007007598A (de)
NL (1) NL1030713C2 (de)
NO (1) NO20073367L (de)
PE (1) PE20060948A1 (de)
PL (1) PL1836211T3 (de)
PT (1) PT1836211E (de)
SI (1) SI1836211T1 (de)
TN (1) TNSN07233A1 (de)
TW (1) TW200626608A (de)
UA (1) UA85937C2 (de)
UY (1) UY29285A1 (de)
WO (1) WO2006067589A1 (de)
ZA (1) ZA200705108B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133212B1 (en) 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
US8367669B2 (en) * 2005-06-15 2013-02-05 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
JP2009506066A (ja) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ，インコーポレイテッド トリアゾール化合物ならびにこれを作製する方法および使用する方法
AU2008224633A1 (en) * 2007-03-13 2008-09-18 Pfizer Products Inc. Erythromycin-based macrolides
EP2136806A4 (de) * 2007-03-21 2011-11-23 Creative Antibiotics Sweden Ab Verfahren und mittel zur prävention und unterdrückung von typ iii sekretion bei infektionen durch gram-negative bakterien
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2009053259A1 (en) * 2007-10-25 2009-04-30 Sandoz Ag Process for the production of telithromycin
EP2225239B1 (de) 2007-12-21 2014-10-22 F. Hoffmann-La Roche AG Heterozyklische antivirale verbindungen
ES2582794T3 (es) 2009-08-13 2016-09-15 Basilea Pharmaceutica Ag Nuevos macrólidos y su uso
CN103080122A (zh) * 2010-03-22 2013-05-01 森普拉制药公司 大环内脂的结晶形式及其用途
WO2012142125A2 (en) 2011-04-12 2012-10-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
CN102558047B (zh) * 2011-12-14 2013-10-30 天津药物研究院药业有限责任公司 3-甲基喹啉的制备方法
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
JP6141428B2 (ja) 2012-07-13 2017-06-07 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 抗増殖性ベンゾ［ｂ］アゼピン−２−オン
KR101612179B1 (ko) * 2013-04-19 2016-04-12 영남대학교 산학협력단 아미도피리딘올 유도체 또는 이의 약제학적 허용가능한 염을 유효성분으로 함유하는 암질환 예방 또는 치료용 약학조성물
TW201534586A (zh) 2013-06-11 2015-09-16 Orion Corp 新穎ｃｙｐ１７抑制劑／抗雄激素劑
CN103739643A (zh) * 2013-12-30 2014-04-23 华东理工大学 利用分子印迹技术对红霉素进行回收分离纯化的方法
CN104230891B (zh) * 2014-08-27 2016-03-30 于宗光 一种托匹司他的制备方法
CN110234323A (zh) * 2016-10-04 2019-09-13 Ti生物制药有限公司 具有抗菌活性的酮内酯
AU2020286381C1 (en) 2019-06-04 2025-07-10 Hager Biosciences, Llc Imidazolo derivatives, compositions and methods as orexin antagonists
JP7837120B2 (ja) * 2019-06-04 2026-03-30 ヘイガー バイオサイエンシズ，エルエルシー オレキシンアンタゴニストとしてのピラゾール及びイミダゾール誘導体、組成物、並びに方法
CN111793022A (zh) * 2020-04-27 2020-10-20 滁州拜奥生物科技有限公司 一种3-甲基喹啉的制备方法
AU2023333164A1 (en) * 2022-09-01 2025-04-03 Hager Biosciences, Llc Pyrazole and imidazole derivatives as dual orexin and kappa-opioid receptors modulators, composition, methods for treating neurological and psychiatric disorders

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653899A (en) 1952-04-14 1953-09-29 Lilly Co Eli Erythromycin, its salts, and method of preparation
US2823203A (en) 1954-06-24 1958-02-11 Abbott Lab Method of producing substantially pure erythromycin a
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
IE70593B1 (en) 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5523399A (en) 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5629322A (en) 1994-11-15 1997-05-13 Merck & Co., Inc. Cyclic amidine analogs as inhibitors of nitric oxide synthase
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
FR2742757B1 (fr) 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO1997042204A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 6-o-substituted erythromycins and method for making them
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
SK285534B6 (sk) 1996-09-04 2007-03-01 Abbott Laboratories 6-O-substituované ketolidy s antibakteriálnou aktivitou, farmaceutická kompozícia s ich obsahom, ich použitie a spôsob ich prípravy
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
CA2272620A1 (en) * 1996-11-27 1998-06-04 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1998042720A1 (fr) 1997-03-24 1998-10-01 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
WO1998051696A1 (en) 1997-05-09 1998-11-19 Pfizer Products Inc. Erythromycin derivatives
US20020025937A1 (en) 2000-03-20 2002-02-28 Yong-Jin Wu 9-oxime erythromycin derivatives
EP0895999A1 (de) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4"-substituierte Macrolidantibiotica
ZA987689B (en) 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
ZA989835B (en) 1997-10-29 1999-05-05 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
PA8461401A1 (es) 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
HN1998000159A (es) 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
ATE275151T1 (de) 1998-03-03 2004-09-15 Pfizer Prod Inc 3,6-ketal-makrolidantibiotika
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
WO1999062920A1 (en) 1998-06-03 1999-12-09 Pfizer Products Inc. Tricyclic 3-keto derivatives of 6-o-methylerythromycin
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
US6020521A (en) 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6262030B1 (en) 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
TR200200436T2 (tr) 1998-11-03 2002-06-21 Pfizer Inc. Yeni makrolit antibiyotikler
ES2273964T3 (es) * 1998-12-10 2007-05-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
AP2001002222A0 (en) 1999-01-27 2001-09-30 Pfizer Prod Inc Ketolide antibiotics.
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
IL145976A0 (en) * 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6395710B1 (en) * 1999-04-16 2002-05-28 Kosan Biosciences, Inc. Macrolide antiinfective agents
US20020061857A1 (en) 1999-04-23 2002-05-23 Yong-Jin Wu 9-amino-3-oxo erythromycin derivatives
US20020077302A1 (en) 1999-04-23 2002-06-20 Yong-Jin Wu Tricyclic erythromycin derivatives
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
IL145739A0 (en) 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
JP2001072669A (ja) 1999-09-07 2001-03-21 Showa Kako Kk ７−クロロ−２，４（１ｈ，３ｈ）−キナゾリンジオンの製造方法
US6569836B2 (en) * 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
EP1114826A3 (de) 1999-12-29 2001-10-31 Pfizer Products Inc. Antibakterielle und prokinetische Makroliden
EP1122261A3 (de) 2000-01-31 2001-09-26 Pfizer Products Inc. 13- und 14-Gliederige Antibakterielle-Makroliden
JP2001261694A (ja) 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
EP1146051A3 (de) 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A-Derivate
US20020061856A1 (en) 2000-04-24 2002-05-23 Yong-Jin Wu Novel tricyclic erythromycin derivatives
TR200401847T4 (tr) 2000-06-30 2004-09-21 Pfizer Products Inc. Makrolit antibiyotikler.
US20020115621A1 (en) 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ES2275621T3 (es) 2000-12-21 2007-06-16 Glaxo Group Limited Antibioticos macrolidos.
US20020132782A1 (en) * 2001-01-18 2002-09-19 Zhenkun Ma 9-amino erythromycin derivatives with antibacterial activity
JP4509553B2 (ja) 2001-07-03 2010-07-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗菌活性を有するｃ１２修飾エリスロマイシンマクロライドおよびケトライド
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7064110B2 (en) 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
PL378841A1 (pl) 2003-04-21 2006-05-29 Daiichi Pharmaceutical Co., Ltd. Pochodna pięcioczłonowego układu heterocyklicznego
RU2397987C2 (ru) 2004-07-28 2010-08-27 Рэнбакси Лабораториз Лимитед Кетолидные производные в качестве антибактериальных агентов
US20090170790A1 (en) 2004-10-25 2009-07-02 Biswajit Das Ketolide derivatives as antibacterial agents
GB0424951D0 (en) 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
US7419962B2 (en) 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
WO2006065721A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
WO2006065743A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. Tetracylic bicyclolides

Also Published As

Publication number Publication date
EP2233493A1 (de) 2010-09-29
ZA200705108B (en) 2009-01-28
PL1836211T3 (pl) 2010-07-30
TW200626608A (en) 2006-08-01
AU2005317735A1 (en) 2006-06-29
EP1836211B1 (de) 2010-03-03
UY29285A1 (es) 2006-07-31
GT200500378A (es) 2006-11-28
CN101120011A (zh) 2008-02-06
UA85937C2 (uk) 2009-03-10
MX2007007598A (es) 2007-07-25
HRP20100253T1 (hr) 2010-06-30
ES2339871T3 (es) 2010-05-26
MA29108B1 (fr) 2007-12-03
EA200701113A1 (ru) 2007-12-28
CA2591746A1 (en) 2006-06-29
JP4111994B1 (ja) 2008-07-02
KR100897678B1 (ko) 2009-05-14
ATE459633T1 (de) 2010-03-15
NL1030713C2 (nl) 2006-12-12
US20060135447A1 (en) 2006-06-22
SI1836211T1 (sl) 2010-04-30
AP2007004026A0 (en) 2007-06-30
DK1836211T3 (da) 2010-05-17
WO2006067589A1 (en) 2006-06-29
CR9202A (es) 2007-07-16
BRPI0519135A2 (pt) 2008-12-23
IL183661A0 (en) 2007-09-20
PT1836211E (pt) 2010-04-08
TNSN07233A1 (fr) 2008-11-21
JP2008524319A (ja) 2008-07-10
AU2005317735B2 (en) 2009-06-04
EA011281B1 (ru) 2009-02-27
KR20070089191A (ko) 2007-08-30
HN2005036113A (es) 2010-12-06
DE602005019786D1 (de) 2010-04-15
GEP20094834B (en) 2009-11-25
EP1836211A1 (de) 2007-09-26
US7462600B2 (en) 2008-12-09
AR052824A1 (es) 2007-04-04
NL1030713A1 (nl) 2006-06-22
PE20060948A1 (es) 2006-10-11

Similar Documents

Publication Publication Date Title
NO20082709L (no) Kjemiske forbindelser
NO20073719L (no) Kjemiske forbindelser
TW200626608A (en) Macrolides
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20074703L (no) Antibakterielle piperidinderivater
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20081844L (no) Terapeutiske forbindelser
WO2007044085A3 (en) Heteroaryl compounds and their uses as therapeutic agents
NO20082538L (no) Stabiliserte lantankarbonatsammensetninger
NO20091605L (no) Pyridinonforbindelser
NO20081212L (no) Xantinderivater som selektive HM74A agonister
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20076675L (no) Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet
NO20061743L (no) Kinazolinderivater
NO20091683L (no) Kjemiske forbindelser
WO2007135527A3 (en) Benzimidazolyl compounds
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO20063449L (no) Substituerte heterocykler og deres anvendelse
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
BRPI0517567A (pt) composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo, composição farmacêutica, usos de um composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo e de uma composição farmacêutica, e, processo para preparar um composto
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
NO20075815L (no) Formuleringer og metoder for behandling av amyloidose
NO20073170L (no) Kaspaseinhibitorer og anvendelse derav
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
WO2008116663A3 (en) Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application